A Study to Evaluate the Safety and Efficacy of Cotadutide Given by Subcutaneous Injection in Adult Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
Clinical trial NCT05364931 · COMPLETED
Trial details
- NCT number
- NCT05364931
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-14
- Primary completion
- 2024-04-19
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.